Cost-Effectiveness of Primary Prevention of Stroke in Type 2 Diabetes in the United States: A Microsimulation Analysis
Recent attention has focused on the treatment of AIS. We demonstrate that substantial opportunities exist to improve the primary prevention of AIS in Americans with T2D. Providers and payers should prioritize adherence to guidelines for BP, statin and aspirin therapy, and smoking cessation for stroke prevention.
Authors
- Shihchen Kuo (ORCID: https://orcid.org/0000-0001-6207-8792)
- Lynda D. Lisabeth (ORCID: https://orcid.org/0000-0001-5539-5933)
- Xiaqing Jiang (ORCID: https://orcid.org/0000-0003-3633-0688)
- Weizhou Zhang (ORCID: https://orcid.org/0000-0002-8236-0346)
- Christopher Becker (ORCID: https://orcid.org/0000-0003-3414-9826)
- William H. Herman (ORCID: https://orcid.org/0000-0002-0502-674X)
- Jing Li (ORCID: https://orcid.org/0000-0002-8197-5963)
- Lewis B. Morgenstern (ORCID: https://orcid.org/0000-0002-5787-592X)
- Wen Ye (ORCID: https://orcid.org/0000-0001-5802-189X)
Institutions
- University of California, San Francisco (US)
- University of Michigan (US)
- University of San Francisco (US)
Publication Details
- Journal
- Journal of General Internal Medicine
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1007/s11606-025-10067-x
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00